Log In
Print this Print this

Zeneo Methotrexate

  Manage Alerts
Collapse Summary General Information
Company Crossject S.A.
DescriptionMethotrexate delivered using the company's Zeneo needle-free injection system
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPilot
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid polyarthritis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today